Cidalcyn 0.00252 % Liquid is a Health Canada–registered disinfectant drug (DIN 02292688) held by Oculus Innovative Sciences, Inc., containing Hypochlorous Acid. Health Canada lists its status as Cancelled (Unreturned Annual) (status date 05 Apr 2018). Nexara Health has matched 4 registrations of Hypochlorous Acid across 2 other regulated markets.
Health Canada registration
| DIN | 02292688 |
|---|---|
| Brand name | Cidalcyn |
| Active ingredient | Hypochlorous Acid |
| Strength | 0.00252 % |
| Dosage form | Liquid |
| Route | DISINFECTANT (Domestic) ; DISINFECTANT (Food Premises) ; DISINFECTANT (Hospital/HC Facilities) ; DISINFECTANT (Institutional/Industrial) |
| Company | Oculus Innovative Sciences, Inc. |
| Status | Cancelled (Unreturned Annual) — 05 Apr 2018 |
| Class | Disinfectant |
| ATC | V07AV TECHNICAL DISINFECTANTS |
| AHFS | 38:00.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Hypochlorous Acid registered in other markets
4 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United Arab Emirates | Nexodyn Acidoxidizing Solution | Biokosmes srl, Italy, Bosisio Parini | Combination | Solution | Active | EDE |
| United Arab Emirates | Nexodyn Acidoxidizing Solution | Biokosmes srl, Italy, Bosisio Parini | Combination | Solution | Active | EDE |
| United Arab Emirates | Nexodyn Acidoxidizing Solution | Biokosmes srl, Italy, Bosisio Parini | Combination | Solution | Active | EDE |
| United States | RoyceDerm Stye Relief Eye Spray. | RoyceDerm LLC | Spray | listed | FDA NDC |
See every manufacturer of Hypochlorous Acid worldwide →
Related molecules (ATC V07AV)
- Alcohol Anhydrous
- Alcohol Denatured
- Alkyl Dimethyl Benzyl Ammonium Saccharinate
- Alkyl Dimethyl Ethylbenzyl Ammonium Chloride
- Benzalkonium Chloride
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cidalcyn (DIN 02292688) marketed in Canada?
No. Health Canada lists DIN 02292688 as Cancelled (Unreturned Annual) as of 05 Apr 2018.
Who holds the Canadian licence for this product?
Oculus Innovative Sciences, Inc. is the company of record in the Health Canada Drug Product Database.
Is Hypochlorous Acid registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02292688, status date 2018-04-05; national medicine registries: EDE, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02292688, status date 2018-04-05; national medicine registries: EDE, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02292688, status date 2018-04-05; national medicine registries: EDE, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.